Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Vivos Therapeutics, Inc. VVOS

Healthcare  —  Medical Devices
0.14 (0.01) (6.67%) as of 25 Sep
Market cap
$4.9M
P/E
0.0×
Insider Buys (last 12m)
Insider Buys alert about insiders buying in the last 12 month
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Vivos Therapeutics, Inc. (VVOS) Business Profile

Updated before January 2025

Company Overview

Vivos Therapeutics, Inc. (NASDAQ: VVOS) is a medical technology company specializing in innovative solutions for the treatment of obstructive sleep apnea (OSA) and other sleep-disordered breathing conditions. Founded in 2007 and headquartered in Highlands Ranch, Colorado, Vivos has positioned itself as a leader in the development of non-invasive, patient-friendly treatment options. The company was co-founded by Dr. David S. Singh, a pioneer in craniofacial sleep medicine, and Kirk Huntsman, who currently serves as the Chief Executive Officer. Vivos’s leadership team includes experienced professionals from the healthcare, medical device, and dental industries, all working toward the mission of improving patient outcomes and quality of life.

Core Business Segments

1. Vivos System

The Vivos System is the company’s flagship offering, a proprietary, non-invasive treatment protocol designed to address the root causes of obstructive sleep apnea. This system combines advanced oral appliance technology with a multidisciplinary therapeutic approach. Key products under this category include:

  • Vivos DNA Appliance®: A custom-fitted oral appliance that promotes craniofacial development and airway expansion.
  • Vivos mRNA Appliance®: Designed for mandibular repositioning and airway remodeling.
  • Vivos Guides®: Pediatric-focused appliances aimed at early intervention for sleep-disordered breathing.

2. Vivos Integrated Practices (VIP) Program

The VIP Program is a comprehensive training and support initiative for dental and medical professionals. It equips practitioners with the knowledge and tools to implement the Vivos System in their practices. The program includes:

  • Clinical training and certification.
  • Marketing and business development support.
  • Access to proprietary diagnostic and treatment planning software.

3. Diagnostic and Imaging Solutions

Vivos also offers diagnostic tools and imaging solutions to aid in the identification and treatment planning of sleep-disordered breathing conditions. These include:

  • Vivos Aire™: A cloud-based diagnostic platform.
  • CBCT Imaging Solutions: Advanced imaging technology for airway analysis.

Business Model

Vivos Therapeutics operates on a hybrid business model that integrates product sales, professional training, and ongoing support services. Revenue is generated through:

  • Product Sales: Direct sales of oral appliances and diagnostic tools to healthcare providers.
  • Subscription Services: Recurring revenue from the VIP Program and software platforms.
  • Licensing Agreements: Partnerships with dental and medical practices to expand the adoption of the Vivos System.

This model allows Vivos to create a sustainable revenue stream while fostering long-term relationships with healthcare providers.

Strategic Direction

Vivos is focused on expanding its market presence and driving innovation in sleep medicine. Key strategic initiatives include:

  • Market Expansion: Increasing adoption of the Vivos System in North America and exploring opportunities in international markets.
  • Product Innovation: Developing new appliances and diagnostic tools to address a broader range of sleep-disordered breathing conditions.
  • Sustainability Goals: Implementing eco-friendly manufacturing practices and reducing the environmental impact of its operations.
  • Collaborations and Partnerships: Building alliances with healthcare organizations, research institutions, and technology providers to enhance its offerings.

Competitive Landscape

Vivos operates in a competitive market that includes both traditional and innovative approaches to sleep apnea treatment. Key competitors include:

  • ResMed Inc.: A global leader in CPAP devices and sleep therapy solutions.
  • Inspire Medical Systems: Known for its implantable neurostimulation devices for sleep apnea.
  • SomnoMed: A provider of oral appliance therapy for sleep-disordered breathing.
  • Philips Respironics: A major player in sleep and respiratory care devices.

Despite the competition, Vivos differentiates itself through its non-invasive, patient-centric approach and focus on addressing the root causes of sleep apnea.

Risk Factors

Vivos faces several risks that could impact its business operations and financial performance, including:

  • Market Dependence: Reliance on the adoption of the Vivos System by healthcare providers.
  • Regulatory Challenges: Compliance with medical device regulations and approval processes.
  • Supply Chain Disruptions: Potential delays in the production and delivery of products.
  • Economic Conditions: Sensitivity to changes in healthcare spending and consumer behavior.

Recent Developments

In recent years, Vivos has made significant strides in expanding its product portfolio and market reach. Notable developments include:

  • Launch of Vivos Aire™: A cloud-based diagnostic platform that enhances the accuracy and efficiency of sleep apnea diagnosis.
  • Partnerships with Dental Practices: Collaborations with leading dental organizations to promote the adoption of the Vivos System.
  • COVID-19 Impact: Adjustments to business operations and increased focus on telehealth solutions during the pandemic.

Investment Considerations

Strengths

  • Innovative, non-invasive treatment solutions.
  • Strong intellectual property portfolio.
  • Growing market demand for sleep apnea treatments.
  • Comprehensive training and support programs for healthcare providers.

Risks

  • High competition in the sleep apnea treatment market.
  • Dependence on healthcare provider adoption.
  • Regulatory and compliance challenges.
  • Potential supply chain disruptions.

Conclusion

Vivos Therapeutics, Inc. is a pioneering company in the field of sleep medicine, offering innovative solutions for the treatment of obstructive sleep apnea. With a strong focus on patient outcomes, market expansion, and product innovation, Vivos is well-positioned to capitalize on the growing demand for non-invasive sleep apnea treatments. While the company faces challenges such as competition and regulatory hurdles, its unique approach and commitment to excellence make it a compelling player in the healthcare industry.